Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200824 · ClinicalTrials.gov registry record · Phase 2
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00200824: Completed Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00200824 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200824, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the body) in prostate tissue that has been removed during prostatectomy, as well as in the blood.
Interventions
- DRUG Soy Isoflavone Nutritional Supplements
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-05 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
What the finished NCT00200824 record still lists
NCT00200824 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Soy Isoflavone Nutritional Supplements is the first listed.
NCT00200824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00200824 about?
NCT00200824 is a clinical study titled "Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health". This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the ...
What is the current status of trial NCT00200824?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-05. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00200824?
The interventions under investigation include: Soy Isoflavone Nutritional Supplements (DRUG).
Who is sponsoring clinical trial NCT00200824?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia